Pharmaceutical companies pay out nearly $8 billion in clinical grants each year to physicians to participate in company-sponsored clinical trials. That is why sponsor companies would like to ensure they are receiving value for the amounts paid and that they are avoiding any issues associated with paying outside the boundaries of fair market value.